Shen KW - Search Results

1

Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis.

Yuan Y, Chen XS, Liu SY, Shen KW. Yuan Y, et al. Among authors: shen kw. AJR Am J Roentgenol. 2010 Jul;195(1):260-8. doi: 10.2214/AJR.09.3908. AJR Am J Roentgenol. 2010. PMID: 20566826

2

Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.

Ma CD, Chen CM, Chen XS, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen ZZ, Shen KW. Ma CD, et al. Among authors: shen zz, shen kw. Anticancer Res. 2008 Sep-Oct;28(5B):3093-7. Anticancer Res. 2008. PMID: 19031963 Free article.

3

[Molecular classification of breast cancers].

Chen XS, Chen SJ, Shen KW. Chen XS, et al. Among authors: shen kw. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):641-3. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173901 Review. Chinese. No abstract available.

4

Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.

Huang O, Chen C, Wu J, Chen S, Chen X, Liu G, Hu Z, Lu J, Wu J, Shao Z, Shen Z, Shen K. Huang O, et al. BMC Cancer. 2009 Oct 21;9:375. doi: 10.1186/1471-2407-9-375. BMC Cancer. 2009. PMID: 19845944 Free PMC article.

5

Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.

Chen XS, Wu JY, Huang O, Chen CM, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Chen XS, et al. Among authors: shen zz, shen kw. Oncol Rep. 2010 May;23(5):1213-20. doi: 10.3892/or_00000752. Oncol Rep. 2010. PMID: 20372832

6

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Chen XS, et al. Among authors: shen zz, shen kw. Tumori. 2010 Jan-Feb;96(1):103-10. doi: 10.1177/030089161009600117. Tumori. 2010. PMID: 20437866

7

Measuring β-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer.

Chen X, Wu J, Lu H, Huang O, Shen K. Chen X, et al. Cancer Sci. 2012 Feb;103(2):262-8. doi: 10.1111/j.1349-7006.2011.02135.x. Epub 2011 Nov 29. Cancer Sci. 2012. PMID: 22035021 Free article.

8

Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.

Chen X, Yuan Y, Gu Z, Shen K. Chen X, et al. Breast Cancer Res Treat. 2012 Aug;134(3):957-67. doi: 10.1007/s10549-012-1990-z. Epub 2012 Feb 28. Breast Cancer Res Treat. 2012. PMID: 22370627

9

Role of chemokine receptor CXCR7 in bladder cancer progression.

Hao M, Zheng J, Hou K, Wang J, Chen X, Lu X, Bo J, Xu C, Shen K, Wang J. Hao M, et al. Biochem Pharmacol. 2012 Jul 15;84(2):204-14. doi: 10.1016/j.bcp.2012.04.007. Epub 2012 Apr 13. Biochem Pharmacol. 2012. PMID: 22525723

10

Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer.

Chen M, Zhan WW, Han BS, Fei XC, Jin XL, Chai WM, Wang DB, Shen KW, Wang WP. Chen M, et al. Among authors: shen kw. Chin Med J (Engl). 2012 Jun;125(11):1862-6. Chin Med J (Engl). 2012. PMID: 22884043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page